ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "immunology"

  • Abstract Number: 1095 • ACR Convergence 2022

    A20(Tnfaip3) in Keratinocytes Restricts an Early Antiviral Gene Program Associated with Psoriatic Skin and Joint Disease

    Bahram Razani1, Jared Liu1, Ryan Tobias1, Sugandh Kumar1, Zhi-Ming Huang1, Wilson Liao2, Barbara Malynn3 and Averil Ma3, 1Dept. of Dermatology, UCSF, San Francisco, 2Dept. of Dermatology, San Francisco, 3Division of Gastroenterology, UCSF, San Francisco

    Background/Purpose: A20 (Tnfaip3) levels are reduced in psoriatic plaques and polymorphisms in the TNFAIP3 gene locus are associated with increased risk for both psoriasis and psoriatic…
  • Abstract Number: 1698 • ACR Convergence 2022

    LINE1 Reverse Transcriptase Inhibitors Abrogate Type 1 Interferon Responses

    Daniel Rios1, Nafeeza Hafeez1, Brian Desrosiers1, Shradha Rao1, Jess Floro1, Joelle Baddour1, Nisha Perez2, Greg Bisacchi2, Oliver Saunders2, Donna Romero1, Menachem Fromer2, Enrique Garcia-Rivera2, Wilson McKerrow2, Julie Behr2, Bryan Thornlow2, Dennis Zaller2, David Proia2 and Wenyan Miao2, 1Rome Therapeutics, Cambridge, MA, 2Rome Tx, Cambridge, MA

    Background/Purpose: Transposable elements (TEs) are mobile DNA elements that can replicate and move from one position to another within the host genome. Through co-evolution, TEs…
  • Abstract Number: 1762 • ACR Convergence 2022

    Stability of Cell Bound Complement Activation Products (CB-CAPs), Multianalyte Assay Panel (MAP) with Algorithm, and Other Autoimmune Biomarkers Among Clinical Patients Throughout the SARS-CoV-2 Pandemic and Vaccination Campaigns

    Mark Rudolph, Rory Bloch, Anja Kammesheidt and Roberta Alexander, Exagen, Inc., Vista, CA

    Background/Purpose: COVID-19 can cause autoantibody signatures in severely ill patients, and widespread emerging post-acute sequelae of SARS-CoV-2 (PASC) share many symptoms consistent with rheumatologic involvement…
  • Abstract Number: 0012 • ACR Convergence 2022

    Role of Type L IFN Signaling on B Cell Pathogenicity in Early Sjögren’s Disease in Mouse Model

    Merri-Grace Allred and Scott Lieberman, University of Iowa, Iowa City, IA

    Background/Purpose: Sjogren's disease is a chronic autoimmune disease autoimmune disease characterized by foci of inflammation of the lacrimal and salivary glands. As disease progresses, B…
  • Abstract Number: 0558 • ACR Convergence 2022

    Molecular Interplay Between Mammalian Target of Rapamycin (mTOR) and the YAP Pathway Mediates Rheumatoid Arthritis Synovial Fibroblast Activation

    Brianne Barker1, Megan Hanlon2, Siobhan Wade1, Douglas Veale3, Ursula Fearon1 and Mary Canavan4, 1Trinity College Dublin, Dublin, Ireland, 2Molecular Rheumatology, Dublin, Ireland, 3St. Vincent's University Hospital, Blackrock, Dublin, Ireland, 4Trinity College, Dublin, Ireland

    Background/Purpose: mTOR is a metabolic master regulator of both innate and adaptive immunity, however its exact role in synovial fibroblasts is unknown. RA synovial fibroblasts…
  • Abstract Number: 0752 • ACR Convergence 2022

    A Phase I Clinical Study to Evaluate the Safety, Tolerance, Pharmacokinetics and Immunogenicity of Ebdarokimab in Patients with Moderate to Severe Plaque Psoriasis

    Rui Chen1, Yu Xia2, Baiyong Li2, Xiang Ni2, Guoqin Wang2, Cui Zhang2, Benchao Chen2, Li Wang2 and Hongzhong Jin3, 1Clinical Pharmacology Research Center, Peking Union Medical College Hospital, State Key Laboratory of Complex Severe and Rare Diseases, NMPA Key Laboratory for Clinical Research and Evaluation of Drug, Beijing Key Laboratory of Clinical PK & PD Investigation for Innovative Drugs, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 2Akeso Biopharma, Inc., Zhongshan, China, 3Department of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Disease, Beijing, China

    Background/Purpose: Interleukin-12 (IL-12) and interleukin-23 (IL-23) are two essential cytokins involved in the immune-mediated inflammatory disorders of psoriasis. Anti-IL-12/IL-23 therapy has been developed for the…
  • Abstract Number: 1164 • ACR Convergence 2022

    Expanded CD8+ T Cell Clones from HLA-B*27-positive Patients with Spondyloarthritis Show Signs of Antigen-experience

    Judith Rademacher1, Katharina Deschler2, Sonja Lacher2, Alina Huth2, Markus Utzt2, Stefan Krebs2, Helmut Blum2, Eduardo Beltrán2, Klaus Dornmair2 and Denis Poddubnyy3, 1Charité Universitätsmedizin Berlin, Berlin, Germany, 2Laboratory for Functional Genome Analysis (LAFUGA), Gene Center of the LMU Munich, Munich, Germany, 3Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité – Universitätsmedizin Berlin, Berlin, Germany

    Background/Purpose: Spondyloarthritis (SpA) is strongly associated with HLA-B27. The arthritogenic antigen hypothesis assumes the existence of specific peptides presented by risk-conferring HLA-B27 alleles to antigen-specific…
  • Abstract Number: 1701 • ACR Convergence 2022

    High TNFAIP3-Transfected Cell Activity: An In Vitro Model for Phagocyte Study of Monogenic Behçet’s Disease Pathophysiology

    Patricia Pontes Aires1, André Cunha1, DANIELA GERENT PETRY PIOTTO1, Maria Teresa Terreri2 and Sandro Perazzio1, 1Universidade Federal de São Paulo, São Paulo, Brazil, 2Universidad Federal São Paulo, São Paulo, Brazil

    Background/Purpose: A20 haploinsufficiency (A20HA), an important monogenic etiology of Behçet's disease (BD), is caused by loss-of-function mutations in TNFAIP3. Although monocytes play an important role…
  • Abstract Number: 1763 • ACR Convergence 2022

    Different Humoral but Similar Cellular Responses of Patients with Autoimmune Inflammatory Rheumatic Diseases Under Disease-modifying Anti-rheumatic Drugs After COVID-19 Vaccination

    Ioana Andreica1, Arturo Blazquez-Navarro2, Jan Sokolar3, Moritz Anft4, Uta Kiltz5, Stephanie Pfaender6, Elena Vidal Blanco7, Timm Westhoff8, Nina Babel8, Ulrik Stervbo9 and Xenofon Baraliakos10, 1Rheumazentrum Ruhrgebiet, Ruhr-Universität-Bochum, Herne, Germany, 2Charité Universitätsmedizin Berlin, Berlin Center for Advanced Therapies, Berlin, Germany, 3Rheumazentrum Ruhrgebiet Herne, Ruhr Universität Bochum, Herne, Germany, 4Marienhospital Herne - Klinik Mitte Medizinische Klinik I - Gastroenterologie, Nieren- und Hochdruckkrankheiten, Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Herne and Ruhr-Universit t Bochum, Medical Department I, Bochum, Germany, 5Rheumazentrum Ruhrgebiet, Herne, Germany, 6Ruhr-Universität Bochum, Medical Department I, Bochum, Germany, 7Ruhr-University Bochum, Department of Molecular and Medical Virology, Bochum, Germany, 8Marienhospital Herne, Ruhr-University Bochum, Herne, Germany, 9Marienhospital Herne - Klinik Mitte Medizinische Klinik I - Gastroenterologie, Nieren- und Hochdruckkrankheiten, Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Herne and Ruhr-Universität Bochum, Medical Department I, Bochum, Germany, 10Rheumazentrum Ruhrgebiet Herne, Herne, Germany

    Background/Purpose: The interplay between humoral and cellular response after vaccination against SARS-CoV-2 in patients (pts.) with autoimmune inflammatory rheumatic diseases (AIRD) remains unknown. To investigate…
  • Abstract Number: 0015 • ACR Convergence 2022

    Differential Antigen Binding of Closely Related Monoclonal ACPA

    Caroline Grönwall1, Anatoly Dubnovitsky1, Philip Titcombe2, Daniel Mueller2 and vivianne malmström1, 1Karolinska Institutet, Stockholm, Sweden, 2University of Minnesota, Minneapolis, MN

    Background/Purpose: Anti-citrullinated protein antibodies (ACPA) are a hallmark of rheumatoid arthritis (RA) and the clonality and antigen targets of ACPA positive B cells can be…
  • Abstract Number: 0568 • ACR Convergence 2022

    The Absence of Blk Leads to Increased Inflammation in a Murine Model of Kawasaki Disease

    Melissa Kleinau1, Mohammed Massumi2, Lysa Langevin2, Paul Tsoukas2, Harper Cheng2, Suzanne Tam2, Trang Duong2 and Rae Yeung3, 1University of Toronto, Toronto, ON, Canada, 2Peter Gilgan Centre for Research and Learning, Toronto, ON, Canada, 3The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Kawasaki Disease (KD) is the leading cause of acquired heart disease in children in developed countries characterized by inflammation of the coronary arteries leading…
  • Abstract Number: 0755 • ACR Convergence 2022

    Immune Responses and Disease Marker Changes Following SARS-CoV-2 mRNA Vaccination in a Cohort of Rheumatic Disease Patients

    Zesheng An1, Xian Zhou1, Yanfeng Li1, Jane Jaquith1, Kathleen McCarthy-Fruin1, Kenneth J. Warrington1, Ali Duarte-Garcia1, Uma Thanarajasingam1, Cornelia M. Weyand2 and Hu Zeng1, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic School of Medicine, Rochester, MN, and Stanford University, Stanford, CA

    Background/Purpose: The immunological responses following 3 doses of SARS-CoV2 mRNA vaccination in rheumatic disease patients are unclear. Furthermore, the impact of SARS-CoV2 mRNA vaccination on…
  • Abstract Number: 1166 • ACR Convergence 2022

    Scleroderma Fibroblasts Induce Alternative Macrophage Activation via an ERK1/2-dependent Mechanism

    Taha Dinc1, Juan-Pablo Zertuche1, Fatima El Adili2, Maria Trojanowska3 and Andreea Bujor3, 1Boston University School of Medicine, Boston, MA, 2Boston University School of Medicine, Revere, MA, 3Boston University, Boston, MA

    Background/Purpose: Activation of the innate immune system in systemic sclerosis (SSc), with an increased number of profibrotic/alternatively-activated macrophages in affected tissues, is an important aspect…
  • Abstract Number: 1704 • ACR Convergence 2022

    Interaction of Macrophages and Natural Killer Cells in Pathogenesis of HIV-1-Associated Inflammatory Arthritis

    Can Sungur1, Gao Hongbo1, Li-ping Yang2, Liang Shan1 and Wayne Yokoyama3, 1Washington University, St. Louis, MO, 2Washington University in St. Louis, St. Louis, MO, 3Washington University School of Medicine, St. Louis, MO

    Background/Purpose: Human immunodeficiency virus (HIV) remains a significant life-threatening agent and burden on public health. Lesser studied and understood aspects of HIV infections include HIV-associated…
  • Abstract Number: 1851 • ACR Convergence 2022

    Phenotype and Genotype of Adult-onset Adenosine Deaminase 2 Deficiency Patients

    Beibei Zu1, rongrong wang2, Xiaorou Wang3, Bingqing Zhang4, Na Xu4, Chengjin Huang4, Min Shen5 and Xuejun Zeng4, 1Department of Rheumatology, Xuzhou Central Hospital, XuZhou, China, 2Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing, China, 3Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, Beijing, China, 4Department of General Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China, 5Department of Rheumatology, Peking Union Medical College Hospital, Beijing, China

    Background/Purpose: Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive autoinflammatory disease, characterized by early‑onset vasculopathy, fever, strokes, livedoid rash, hepatosplenomegaly, and hematologic dysfunction,…
  • « Previous Page
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • 24
  • …
  • 33
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology